Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
305.99
+2.71 (+0.89%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
37
38
Next >
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
March 24, 2023
The company is working on an oral version of its cult-following injection, Ozempic.
Via
Investor's Business Daily
Nvidia's Artificial Intelligence Market Strategy Impresses Wall Street
March 22, 2023
Analysts on Wednesday praised Nvidia's approach to artificial intelligence as it moves deeper into software and services. NVDA stock rose.
Via
Investor's Business Daily
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment'
March 21, 2023
Nvidia on Tuesday demonstrated how its technology is advancing artificial intelligence in myriad industries. Nvidia stock has soared in 2023.
Via
Investor's Business Daily
Looking At Amgen's Recent Unusual Options Activity
March 20, 2023
Via
Benzinga
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
March 20, 2023
These businesses are performing much better than their stock prices would suggest.
Via
The Motley Fool
Amgen Unusual Options Activity For March 15
March 15, 2023
Via
Benzinga
Price Over Earnings Overview: Amgen
March 15, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
March 15, 2023
These two companies are showering shareholders with market-topping payouts.
Via
The Motley Fool
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
March 14, 2023
Via
Benzinga
Is It Time to Buy the Dow Jones' 3 Worst-Performing February (and Now March) Stocks?
March 16, 2023
Several blue chips have been routed lately, but most of their sell-offs were way overdone.
Via
The Motley Fool
Amgen's Debt Overview
March 14, 2023
Via
Benzinga
2 Stocks to Buy Near Their 52-Week Lows That Could Help You Beat The Market
March 14, 2023
Let's follow one of the most basic investment tips: Buy low.
Via
The Motley Fool
What 14 Analyst Ratings Have To Say About Amgen
March 13, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Death Cross Looms Over Amgen Investors
March 07, 2023
Via
Benzinga
A Look Into Amgen's Debt
March 01, 2023
Shares of Amgen Inc. (NASDAQ:AMGN) fell by 17.83% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Via
Benzinga
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.
Via
Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks Delivering High-Dividend Yields
March 10, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
A Bull Market Is Coming: 3 Stocks Near Their 52-Week Lows to Buy Now
March 08, 2023
It may only be a matter of time before these stocks start to rally.
Via
The Motley Fool
Want Growing Passive Income? Buy This Dow Jones Stock
February 22, 2023
This big pharma company possesses a solid drug pipeline.
Via
The Motley Fool
7 Over-$100 Stocks That Are Worth Every Penny
March 03, 2023
To get most of the best-known stocks, you have to be prepared to pay at least $100 per share. Here are seven stocks to buy.
Via
InvestorPlace
Could This Humira Biosimilar Be a Winner for Amgen?
March 03, 2023
This Humira biosimilar just launched in the U.S. several weeks ago.
Via
The Motley Fool
3 Value Stocks You'll Regret Not Buying on the Dip
March 01, 2023
These three undervalued healthcare stocks are solid picks for patient investors.
Via
The Motley Fool
Want More Reliable Dividend Income? Buy This Dividend King.
February 22, 2023
This big pharma company possesses a deep drug portfolio and pipeline.
Via
The Motley Fool
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.
Via
The Motley Fool
AMGN Near Buy Point With Strong Fundamentals And Rising Dividend
February 16, 2023
AMGN is a steady long-term performer and offers a nice upside for a several-month trade or longer.
Via
Talk Markets
Devon Energy, Broadcom, Amgen And This Company Report Earnings Next Week: CNBC's 'Final Trades'
February 16, 2023
On CNBC’s "Halftime Report Final Trades," Requisite Capital Management's Bryn Talkington praised Devon Energy Corporation (NYSE: DVN) for its free cash flow.
Via
Benzinga
Is This the Start of a Nightmare for AbbVie Stock?
February 16, 2023
With a competitor set to devour market share, stormy waters might be ahead.
Via
The Motley Fool
2 Market-Beating Dividend Stocks to Buy With $500
February 16, 2023
These two leading healthcare stocks have been rewarding shareholders with dividends for a while.
Via
The Motley Fool
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.